Search results
Results from the WOW.Com Content Network
Lancet Neurology is a peer-reviewed scientific journal that was established in 2002 by Elsevier BV. Abstracting and indexing. Lancet Neurology is abstracted and ...
The Lancet Child & Adolescent Health (paediatrics) launched in 2017. According to the Journal Citation Reports, The Lancet Oncology had a 2021 impact factor of 54.433, The Lancet Neurology had 59.935, and The Lancet Infectious Diseases had 71.421. [8] There is also an online website for students entitled The Lancet Student in blog format ...
Becker-Barroso joined in the editorial department of Lancet Neurology in 2005 [1] before becoming the editor-in-chief of in 2012. [3] Selected publications.
Thomas Solomon is Professor of Neurology at the University of Liverpool, director of The Pandemic Institute [3] [4] and director of the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections. [5] [6] [7] He is also vice president (international) of the Academy of Medical Sciences.
[7] [8] In 2009, she received the David Marsden Award from the European Dystonia Society [9] for her 2009 paper published in The Lancet Neurology. [10] In 2011 Schneider received the Jon Stolk Award in Movement Disorders for Young Investigators from the American Academy of Neurology. [11]
He serves on the editorial boards of the journals Brain, Lancet Neurology, Neurogenetics, Journal of Parkinson's Disease, Journal of Huntington's Disease, npj Parkinson's Disease, and Neurodegenerative Diseases; He is Associate Editor for Genetics at the journals npj Parkinson's Disease and Movement Disorders
The Lancet Neurology 8 (7), 643–653. (961 citations) E Tournier-Lasserve, A Joutel, J Melki, J Weissenbach, GM Lathrop, et al. 1993. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature genetics 3 (3), 256–259. (729 citations)
The Lancet Neurology, Volume 8, Issue 2.---., et al. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. The Lancet, Volume 383, Issue 9916.---., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, Dec 2005, 65 (12).